The Impact of COVID-19 on Academic Cancer Clinical Trials in Canada and the Initial Response from Cancer Centers

The Impact of COVID-19 on Academic Cancer Clinical Trials in Canada and the Initial Response from Cancer Centers

The COVID-19 pandemic resulted in temporary holds placed on new trial startups, patient recruitment and follow up visits for trials which contributed to major disruptions in cancer center trial unit operations. To assess the impact, the Canadian Cancer Clinical Trials Network (3CTN) members particip...

Full description

Bibliographic Details
Main Authors:	Stephen Sundquist, Diana Kato, Rebecca Y. Xu, James Schoales, Saranya Kulendran, Janet E. Dancey
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Current Oncology
Subjects:	Canadian cancer clinical trials academic cancer trials COVID-19 pandemic impact trial site activations
Online Access:	https://www.mdpi.com/1718-7729/29/4/197

Similar Items

Advancing Academic Cancer Clinical Trials Recruitment in Canada
by: Rebecca Y. Xu, et al.
Published: (2021-07-01)

CRAFT—A Proposed Framework for Decentralized Clinical Trials Participation in Canada
by: Stephen Sundquist, et al.
Published: (2021-09-01)

Patient and Patient Group Engagement in Cancer Clinical Trials: A Stakeholder Charter
by: Stéphanie Michaud, et al.
Published: (2021-04-01)

Gatekeeping in cancer clinical trials in Canada: The ethics of recruiting the “ideal” patient
by: Jennifer A. H. Bell, et al.
Published: (2020-06-01)

Exploring the divergence in perspectives on clinical trial operations in South Korea during the COVID-19 pandemic: a comparison of a trial site and sponsors
by: Young-Sang Kim, et al.
Published: (2024-03-01)

The Impact of COVID-19 on Cancer Clinical Trials Conducted by NCI-Designated Comprehensive Cancer Centers
by: Diviya Gupta, et al.
Published: (2021-05-01)

Evaluating cancer research impact: lessons and examples from existing reviews on approaches to research impact assessment
by: Catherine R. Hanna, et al.
Published: (2021-03-01)

Randomized phase II cancer clinical trials /
by: Jung, Sin-Ho, author
Published: ([201)

Conducting non-commercial international clinical trials: the ICR-CTSU experience
by: Lisa Fox, et al.
Published: (2017-09-01)

Challenges to Recruiting Men on Active Surveillance for Prostate Cancer in Clinical Chemoprevention Trials
by: Nagi B. Kumar, et al.
Published: (2023-02-01)

First-line single-agent panitumumab in frail elderly patients with wild-type RAS unresectable colorectal cancer: a phase II study protocol OGSG 1602
by: Tetsuji Terazawa, et al.
Published: (2019-06-01)

COVID-19 site readiness initiative: Building clinical trial capacity for vaccine efficacy trials in Latin America in response to the pandemic
by: Sue Ann Costa Clemens, et al.
Published: (2022-12-01)

Knowledge, attitudes, and perception of 398 cancer patients toward participation in clinical trials: A single-center study from New Delhi, India
by: Vishal Kumar Biswkarma, et al.
Published: (2022-01-01)

Academic clinical trials: Publication of study results on an international registry—We can do better!
by: Jean-Marc Hoffmann, et al.
Published: (2022-11-01)

TBCRC 057: Survey about willingness to participate in cancer clinical trials during the pandemic
by: Karen Lisa Smith, et al.
Published: (2024-03-01)

Investigator-initiated clinical trials conducted by the Portuguese Clinical Research Infrastructure Network (PtCRIN)
by: C. Madeira, et al.
Published: (2016-12-01)

Increasing patient participation in oncology clinical trials
by: Jie Chen, et al.
Published: (2023-02-01)

Learning from patient and site perspectives to develop better digital health trials: Recommendations from the Clinical Trials Transformation Initiative
by: Cindy Geoghegan, et al.
Published: (2020-09-01)

Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer
by: Daniel J. García-Domínguez, et al.
Published: (2024-01-01)

Monitoring in practice – How are UK academic clinical trials monitored? A survey
by: Sharon B. Love, et al.
Published: (2020-01-01)

Current Targeted Therapy for Metastatic Colorectal Cancer
by: Tomokazu Ohishi, et al.
Published: (2023-01-01)

It is unprecedented: trial management during the COVID-19 pandemic and beyond
by: Eleanor J. Mitchell, et al.
Published: (2020-09-01)

Building internal capacity in pragmatic trials: a workshop for program scientists at the US National Cancer Institute
by: Wynne E. Norton, et al.
Published: (2019-12-01)

Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments
by: Robbe Saesen, et al.
Published: (2023-06-01)

Spotlight on landmark oncology trials: the latest evidence and novel trial designs
by: Helena Earl, et al.
Published: (2017-06-01)

National Cancer Institute Smoking Cessation at Lung Examination Trials Brief Report: Baseline Characteristics and Comparison With the U.S. General Population of Lung Cancer Screening–Eligible Patients
by: Rafael Meza, PhD, et al.
Published: (2022-07-01)

Investigator-initiated studies: Challenges and solutions
by: Mahanjit Konwar, et al.
Published: (2018-01-01)

The Potential of Trial-by-Trial Variabilities of Ongoing-EEG, Evoked Potentials, Event Related Potentials and fMRI as Diagnostic Markers for Neuropsychiatric Disorders
by: Carlos Trenado, et al.
Published: (2019-07-01)

Addressing disparities in cancer clinical trials: a roadmap to more equitable accrual
by: Jon A. Hoin, et al.
Published: (2024-03-01)

Brief Report: Implementation of a Universal Prescreening Protocol to Increase Recruitment to Lung Cancer Studies at a Veterans Affairs Cancer Center
by: Jenny J. Xiang, MD, et al.
Published: (2022-07-01)

A single experience in the conduction of clinical trial during COronaVIrusDisease-2019 pandemic
by: Zelmira Ballatore, et al.
Published: (2023-09-01)

Most children with cancer are not enrolled on a clinical trial in Canada: a population-based study
by: Jason D. Pole, et al.
Published: (2017-06-01)

Barriers to non-small cell lung cancer trial eligibility
by: Jeffrey J. Hardesty, et al.
Published: (2018-03-01)

Sponsors’ participation in conduct and reporting of industry trials: a descriptive study
by: Lundh Andreas, et al.
Published: (2012-08-01)

Clinical trials in oncology /
by: 214712 Green, Stephanie, et al.
Published: (2003)

Bolstering the complex study start-up process at NCI cancer centers using technology
by: Dinesh Pal Mudaranthakam, et al.
Published: (2022-12-01)

Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges
by: Ryan Green, et al.
Published: (2022-10-01)

Transparency in ovarian cancer clinical trial results: ClinicalTrials.gov versus PubMed, Embase and Google scholar
by: Anna Roberto, et al.
Published: (2018-04-01)

Pharmaceutical industry funding and chemotherapy trials for prostate cancer: A systematic review
by: Amirreza Heydari, et al.
Published: (2023-01-01)

Probiotics in Cancer
by: Ke Lu, et al.
Published: (2021-03-01)